Clinical Trials in Miami, FL

Browse 246 Clinical Trials Miami Across 1176 Cities
108 Phase 3 Trial · 8597 Clinical Trials Miami Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Miami, FL

Reviewed by Michael Gill, B. Sc.

Image of USPA Advance Concept Medical Research Group LLC in Miami, United States.

Phase-Based Progress Estimates

Nirmatrelvir Plus Ritonavir For 5 Daysfor COVID19 (disease)

The purpose of this study is to learn about the safety and effects of nirmatrelvir/ritonavir for the potential treatment of COVID-19 rebound. The study is seeking participants who: Have completed treatment with nirmatrelvir/ritonavir Have a rebound in COVID-19 symptoms Are SARS-CoV-2 (COVID-19) positive All study medications will be taken 2 times a day by mouth for 5 days. The first dose of study medication is taken at the study clinic and the rest at home. We will examine the experiences of people receiving the study medicines to those who do not. This will help us determine if the study medicines are safe and effective. People taking part will be in this study for about 24 weeks. Enrolled participants will need to visit the study clinic at least 8 times during the study.

USPA Advance Concept Medical Research Group LLC (+10 Sites)Pfizer CT.gov Call CenterPfizer

Image of Lenzmeier Family Medicine/CCT Research in Glendale, United States.

Phase-Based Progress Estimates

Quadrivalent Influenza ModRNA Vaccinefor Influenza, Human

This trial will compare the efficacy of a new quadrivalent influenza modRNA vaccine to a licensed inactivated influenza vaccine in healthy adults 18 years and older.

Lenzmeier Family Medicine/CCT Research (+99 Sites)Pfizer CT.gov Call CenterPfizer

Image of University of Alabama at Birmingham - The Kirklin Clinic in Birmingham, United States.

Phase-Based Progress Estimates

Aticaprantfor Psychosis, Involutional

This trial is testing a new drug to see if it's safe and effective when used with current antidepressants to treat people with major depressive disorder.

University of Alabama at Birmingham - The Kirklin Clinic (+42 Sites)Janssen Research & Development, LLC Clinical trialJanssen Research & Development, LLC

Image of Novo Nordisk Investigational Site in Pembroke Pines, United States.

Phase-Based Progress Estimates

Semaglutide Jfor Diabetes Mellitus, Type 2

This trial is testing a new way to make the diabetes drug semaglutide, to see if it controls blood sugar better than the current version.

Novo Nordisk Investigational Site (+45 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of Research Centers of America ( Hollywood ) ( Site 0002) in Hollywood, United States.

Phase-Based Progress Estimates

Molnupiravirfor Hepatic Impairment

This trial will study the effects of a single dose of molnupiravir on N-hydroxycytidine levels in people with moderate hepatic impairment and healthy controls.

Research Centers of America ( Hollywood ) ( Site 0002) (+2 Sites)Medical DirectorMerck Sharp & Dohme LLC

Image of Local Institution in Rogers, United States.

Phase-Based Progress Estimates

Nivolumab-relatlimab FDCfor Colorectal Cancer

This trial will test a new drug combination for people with metastatic colorectal cancer who have failed other treatments.

Local Institution (+22 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Clinical Study Site in Lafayette, United States.

Phase-Based Progress Estimates

MORF-057for Colitis, Ulcerative

This trial will test if a new medication is effective and safe for people with moderate to severe ulcerative colitis.

Clinical Study Site (+10 Sites)Morphic Therapeutic, Inc

Image of Carolina Biooncology Institute in Huntersville, United States.

Phase-Based Progress Estimates

AU-007 Combined With Aldesleukin Given Concomitantlyfor Metastatic Cancers

This trial is testing a new drug, AU-007, to see if it is safe and effective in treating people with advanced solid tumors.

Carolina Biooncology Institute (+3 Sites)Aulos Bioscience, Inc.

Image of Bausch Site 001 in Palmetto Bay, United States.

Phase-Based Progress Estimates

Rifaximin SSDfor Hepatic Coma

FDA Approved Drug

This trial is testing whether a drug can help prevent hepatic encephalopathy, a complication of liver cirrhosis, in people who have not had it before.

FDA Approved Drug

Bausch Site 001 (+90 Sites)John LaheyBausch Health Americas, Inc.

Image of Hoag Memorial Hosp Presbyterian /ID# 233555 in Irvine, United States.

Phase-Based Progress Estimates

ABBV-154for Ileocolitis

This trial is evaluating the safety and effectiveness of ABBV-154 in people with Crohn's disease.

Hoag Memorial Hosp Presbyterian /ID# 233555 (+31 Sites)ABBVIE INC.AbbVie

Image of PIH Health Hospital in Whittier, United States.

Phase-Based Progress Estimates

Risk Factor Managementfor Cerebral Atherosclerosis

FDA Approved Drug

This trial is testing whether two drugs are better than one at preventing strokes.

FDA Approved Drug

PIH Health Hospital (+42 Sites)Brian Hoh, MD, MBAAstraZeneca

Image of Summit - Southern Therapy and Advanced Research in Jackson, United States.

Phase-Based Progress Estimates

Setanaxibfor Primary Biliary Cholangitis

This trial is studying setanaxib to see if it can improve outcomes in people with primary biliary cholangitis who haven't responded well to other treatments.

Summit - Southern Therapy and Advanced Research (+26 Sites)Genkyotex Suisse SA

Image of Research Site in Mesa, United States.

Phase-Based Progress Estimates

BIIB059for Libman-Sacks Disease

This trial is testing a new drug for Lupus called BIIB059. The objective is to see if it is more effective than a placebo in reducing disease activity. There are also secondary objectives to see if it has early onset of efficacy, if it works on specific parts of the body, and if it has other benefits. Finally, they will assess the safety and tolerability of the drug.

Research Site (+35 Sites)Medical DirectorBiogen

Image of Rehabilitation and Neurological Services LLC in Huntsville, United States.

Phase-Based Progress Estimates

Erenumabfor Migraine

FDA Approved Drug

This trial will study how well erenumab works to improve satisfaction with migraine medication.

FDA Approved Drug

Rehabilitation and Neurological Services LLC (+41 Sites)MDAmgen

Image of Pinnacle Research Group (Site 1082), 321 E. 10th Street in Anniston, United States.

Phase-Based Progress Estimates

BRII-196/BRII-198for Communicable Diseases

Waitlist Available

FDA Approved Drug

This trial is testing multiple drugs from different companies to see if they can prevent COVID-19 progression to more serious symptoms.

Waitlist Available

FDA Approved Drug

Pinnacle Research Group (Site 1082), 321 E. 10th Street (+99 Sites)David Smith, MD, MASAstraZeneca

Image of Lombardi Comprehensive Cancer Center in Washington, United States.

Phase-Based Progress Estimates

Patient Observationfor Melanoma

FDA Approved Drug

This trial is testing if doctors can safely shorten the use of anti-PD1 therapy for melanoma by using biomarkers seen on PET/CT imaging and tumor biopsy.

FDA Approved Drug

Lombardi Comprehensive Cancer Center (+99 Sites)Geoffrey T Gibney

Image of University of Miami, Sylvester Comprehensive Cancer Center in Miami, United States.

Phase-Based Progress Estimates

KER-050 Cohort 2for Myelodysplastic Syndromes

The purpose of this study is to evaluate the effects of KER-050 on anemia in patients with very low, low or intermediate risk MDS.

University of Miami, Sylvester Comprehensive Cancer CenterKeros Therapeutics

Image of Investigational Site Number 1240004 in Edmonton, Canada.

Phase-Based Progress Estimates

Isatuximab SAR650984for Neoplasms, Plasma Cell

FDA Approved Drug

This trial is testing a drug to see if it can help people with a certain type of cancer.

FDA Approved Drug

Investigational Site Number 1240004 (+7 Sites)Clinical Sciences & OperationsSanofi

Image of Acurx Site #101 in Miami, United States.

Phase-Based Progress Estimates

Ibezapolstatfor Clostridium Infections

FDA Approved Drug

This trial is testing a new drug to treat C. difficile infection. The drug is safe and effective, and also affects the microbiome.

FDA Approved Drug

Acurx Site #101 (+44 Sites)Michael H Silverman, MDAcurx Pharmaceuticals LLC

Image of University of Alabama at Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

VAL-083for Glioblastoma

FDA Approved Drug

This trial is designed to test multiple therapies for glioblastoma, a type of brain cancer.

FDA Approved Drug

University of Alabama at Birmingham (+4 Sites)Tim Cloughesy, MDBayer

Image of Southern California Research Center in Coronado, United States.

Phase-Based Progress Estimates

Standard Medical Treatmentfor Liver Cirrhosis

FDA Approved Drug

This trial will compare the standard treatment for decompensated cirrhosis plus Albutein to standard treatment alone, in order to evaluate the efficacy of Albutein.

FDA Approved Drug

Southern California Research Center (+8 Sites)Instituto Grifols, S.A.

Image of Elite Clinical Studies, LLC in Phoenix, United States.

Phase-Based Progress Estimates

Ozanimodfor Ileocolitis

FDA Approved Drug

This trial is testing a new drug to see if it can help Crohn's Disease patients who are in moderate to severe pain.

FDA Approved Drug

Elite Clinical Studies, LLC (+65 Sites)Kanthi Kollengode, MDCelgene

Image of City of Hope National Medical Center in Duarte, United States.

Phase-Based Progress Estimates

Magrolimabfor Cancer

Waitlist Available

FDA Approved Drug

This trial is testing the safety and efficacy of magrolimab, a new drug, in people with relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome. The primary objectives are to confirm the safety and tolerability of magrolimab and to evaluate the efficacy of magrolimab in achieving complete remission.

Waitlist Available

FDA Approved Drug

City of Hope National Medical Center (+22 Sites)Gilead Study DirectorGilead Sciences

Image of University Of Miami Miller School of Medicine in Miami, United States.

Phase-Based Progress Estimates

Rosuvastatinfor Spinal Cord Injuries

Waitlist Available

FDA Approved Drug

This trial is testing whether a drug called Rosuvastatin can help to reduce bone loss and inflammation in people with long-term spinal cord injuries.

Waitlist Available

FDA Approved Drug

University Of Miami Miller School of Medicine (+1 Sites)B. Catharine Craven, BA, MD, FRCPC, MSc

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Cyclophosphamidefor Ganglioneuroblastoma

FDA Approved Drug

This trial looks at a new way to treat neuroblastoma that may be more effective and have fewer side effects.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Holly J Meany

25 Clinical Trials Miami Near Me

Top Cities for Clinical Trials Miami

Image of Miami in Florida.

Miami

405Active Trials

University of Miami Miller School of Medicine-Sylvester Cancer CenterTop Active Site

Image of New York in New York.

New York

148Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site